Status:
COMPLETED
Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19）
Lead Sponsor:
RenJi Hospital
Conditions:
Covid19
Echocardiography
Eligibility:
All Genders
18+ years
Brief Summary
The cardiovascular effects of coronavirus disease 2019 (COVID-19) are not yet fully known. We conducted a prospective and dynamic echocardiographic study to investigate the cardiac structural and func...
Detailed Description
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the newly discovered severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2) has become a global health crisis, resulting in 3...
Eligibility Criteria
Inclusion
- Patients had been diagnosed of COVID-19 according to the criteria established by the WHO interim guidance and admitted to ICU because of severe or critical condition
Exclusion
- Patients who were \< 18 years and whose entire stay in hospital lasted for \< 48 hours.
Key Trial Info
Start Date :
January 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 8 2020
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04352842
Start Date
January 21 2020
End Date
April 8 2020
Last Update
May 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China, 200127